Clinical trial patient recruitment saw a lot of advancements in 2022, from patient concierge programs to DEI enrollment strategies. But what’s in store for 2023? We asked six of our industry experts to weigh in with their predictions.
Clinical trial patient recruitment saw a lot of advancements in 2022, from patient concierge programs to DEI enrollment strategies. But what’s in store for 2023? We asked six of our industry experts to weigh in with their predictions.
Topics: Most Viewed, Rob Laurens, Aaron Fleishman, Elizabeth Gargill, Crystal Ball, Michael Turner, 2023 Predictions, Andre Briola, Erica Mercado
We are all hoping that 2022 will be a better year for the world, one where the impact of the pandemic truly begins to subside for everyone around the globe. That said, it is a basic truth that every challenge presents some opportunity, and the impact of COVID-19 on the clinical research and development industry has been no exception.
Topics: Rob Laurens, Decentralized Clinical Trials, Hybrid Clinical Trials, Crystal Ball, Concierge, Site Centricity
The clinical trial landscape saw a lot of changes in 2021, from decentralized clinical trial adoption to a greater emphasis on diversity and inclusion. But what’s in store for 2022? We asked our industry experts to weigh in with their predictions.
Topics: Most Viewed, Aaron Fleishman, Mike Johnson, Danielle Frate, Dena Raffa, 2022 Predictions, Justin Jones, Crystal Ball